Phacoemulcification with intravitreal bevacizumab injection in patients with cataract and coexisting diabetic retinopathy: Prospective randomized study

Journal of Ocular Pharmacology and Therapeutics

Volumn 28, Issue 3, 2012, Pages 212-218

  Salehi, Ali ^a   Beni, Afsaneh Naderi ^a   Razmjoo, Hassan ^b   Beni, Zahra Naderi ^a  

^a SHAHREKORD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB;

ADULT; ARTICLE; CATARACT; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISEASE COURSE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; MALE; NEOVASCULAR GLAUCOMA; PHACOEMULSIFICATION; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RETINA MACULOPATHY; TREATMENT OUTCOME; VISUAL ACUITY;

AGED; ANTIBODIES, MONOCLONAL, HUMANIZED; CATARACT; DIABETIC RETINOPATHY; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTRAVITREAL INJECTIONS; LENS IMPLANTATION, INTRAOCULAR; MACULAR EDEMA; MALE; MIDDLE AGED; OPHTHALMOSCOPY; PHACOEMULSIFICATION; PROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY;

EID: 84862190779     PISSN: 10807683     EISSN: 15577732     Source Type: Journal    
DOI: 10.1089/jop.2011.0069     Document Type: Article

References (67)

1. Klein, B.E., Klein, R., and Moss, S.E. Prevalence of cataracts in a population-based study of persons with diabetic mellitus. Ophthalmology 92:1191-1196, 1985. (Pubitemid 15239383)
2. Nielsen, N.V., and Vinding, T. The prevalence of cataract in insulin-dependent and non-insulin-dependent diabetes mellitus. Acta. Ophthalmol. Scand. 62:595-602, 1984. (Pubitemid 14057299)
3. Sadiq, S.A., Sleep, T., and Amoaku, W.M. The visual results and changes in retinopathy in diabetic patients following cataract surgery. Eur. J. Ophthalmol. 9:14-20, 1999. (Pubitemid 29179941)
4. Cunliffe, I.A., Flanagan D.W., George, N.D.L., Aggarwaal, R.J., and Moore, A.T. Extracapsular cataract surgery with lens implantation in diabetics with and without proliferative retinopathy. Br. J. Ophthalmol. 75:9-12, 1991.
5. Sadiq, S.A., Chatterjee, A., and Vernon, S.A. Progression of diabetic retinopathy and rubeotic glaucoma following cataract surgery. Eye 9:728-738, 1995.
6. Henricsson, M., Heijl, A., and Janzon, L. Diabetic retinopathy before and after cataract surgery. Br. J. Ophthalmol. 80:789-793, 1996. (Pubitemid 26345306)
7. Jaffe, G.J., Burton, T.C., Kuhn, E., Prescott, A., and Hartz, A. Progression of nonproliferative diabetic retinopathy and visual outcome after extracapsular cataract extraction and intraocular lens implantation. Am. J. Ophthalmol. 114:448-456, 1992.
8. Chung, J., Kim, M.Y., Kim, H.-S., Joo, J.-S., and Lee, Y.-C. Effect of cataract surgery on the progression of diabetic retinopathy. J. Cataract. Refract. Surg. 28:626-630, 2002. (Pubitemid 34286781)
9. Zaczek, A., Olivestedt, G., and Zetterström, C. Visual outcome after phacoemulsification and IOL implantation in diabetic patients. Br. J. Ophthalmol. 83:1036-1041, 1999. (Pubitemid 29433425)
10. Aiello, L.P., Avery, R.L., Arrigg, P.G., Keyt, B.A., Jampel, H.D., Shah, S.T., et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N. Engl. J. Med. 331:1480-1487, 1994. (Pubitemid 24356306)
11. Adamis, A.P., Miller, J.W., Bernal, M.T., D'Amico, D.J., Folkman, J., Yeo, T.K., et al. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am. J. Ophthalmol. 118:445-450, 1994.
12. Cunningham, E.T., Adamis, A.P., Altaweel, M., Aiello, L.P., Bressler, N.M., D'Amico, D.J., et al. A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema. Ophthalmology 112:1747-1757, 2005.
13. Chun, D.W., Heier, J.S., Topping, T.M., Duker, J.S., and Bankert, J.M. A pilot study of multiple intravitreal injections of ranibizumab in patients with center-involving clinically significant diabetic macular edema. Ophthalmology 113:1706-1712, 2006. (Pubitemid 44442451)
14. Iturralde, D., Spaide, R.F., Meyerle, C.B., Klancnik, J.M., Yannuzzi, L.A., Fisher, Y.L., et al. Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short term study. Retina 26:279-284, 2006. (Pubitemid 44318180)
15. Spandau, U.H., Ihloff, A.K., and Jonas, J.B., Intravitreal bevacizumab treatment of macular oedema due to central retinal vein occlusion. Acta. Ophthalmol. Scand. 84:555-556, 2006. (Pubitemid 44109048)
16. Spaide, R.F., Laud, K., Fine, H.F., Klancnik, J.M., Jr., Meyerle, C.B., Yannuzzi, L.A., et al. Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration. Retina 26:383-390, 2006. (Pubitemid 44197628)
17. Rich, R.M., Rosenfeld, P.J., Puliafito, C.A., Dubovy, S.R., Davis, J.L., Flynn, H.W., Jr., et al. Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Retina 26:495-511, 2006. (Pubitemid 44620390)
18. Ladewig, M.S., Ziemssen, F., Jaissle, G., Helb, H.M., Scholl, H.P., Eter, N., et al. Intravitreal bevacizumab for neovascular age-related macular degeneration. Ophthalmologe 103:463-470, 2006. (Pubitemid 43892184)
19. Oshima, Y., Sakaguchi, H., Gomi, F., and Tano, Y. Regression of iris neovascularization after intravitreal injection of bevacizumab in patients with proliferative diabetic retinopathy. Am. J. Ophthalmol. 142:155-158, 2006.
20. Bakri, S.J., Donaldson, M.J., and Link, T.P. Rapid regression of disc neovascularization in a patient with proliferative diabetic retinopathy following adjunctive intravitreal bevacizumab. Eye 20:1474-1475, 2006. (Pubitemid 44921215)
21. Mason, J.O., 3rd, Albert, M.A., Jr., Mays, A., and Vail, R. Regression of neovascular iris vessels by intravitreal injection of bevacizumab. Retina 26:839-841, 2006. (Pubitemid 44386115)
22. Shah, P.K., Narendran, V., Tawansy, K.A., Raghuram, A., and Narendran, K. Intravitreal bevacizumab (Avastin) for post laser anterior segment ischemia in aggressive posterior retinopathy of prematurity. Indian J. Ophthalmol. 55:75-76, 2007. (Pubitemid 46065943)
23. Ozturk, B.T., Kerimoglu, H., Bozkurt, B., and Okudan, S. Comparison of intravitreal bevacizumab and ranibizumab treatment for diabetic macular edema. J. Ocul. Pharmacol. Ther. 27:373-377, 2011.
24. Avery, R.L., Pearlman, J., Pieramici, D.J., et al. Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy. Ophthalmology 113:1695, 2006.
25. Spaide, R.F., and Fisher, Y.L. Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage. Retina 26:275-278, 2006. (Pubitemid 44318179)
26. Rosenfeld, P.J. Intravitreal Avastin: the low cost alternative to Lucentis? Am. J. Ophthalmol. 142:141-143, 2006. (Pubitemid 43946805)
27. Gillies, M.C. What we don't know about Avastin might hurt us. Arch. Ophthalmol. 124:1478-1479, 2006. (Pubitemid 44537150)
28. Shahar, J., Avery, R.L., Heilweil, G., Barak, A., Zemel, E., Lewis, G.P., et al. Electrophysiologic and retinal penetration studies following intravitreal injection of bevacizumab (Avastin). Retina 26:262-269, 2006. (Pubitemid 44318177)
29. Schatz, H., Aticnza, D., McDonald, H.R., and Johnson, R.N. Severe diabetic retinopathy after cataract surgery. Am. J. Ophthalmol. 117:314-321, 1994. (Pubitemid 24081416)
30. Pollack, A., Dotan, S., and Oliver, M. Progression of diabetic retinopathy after cataract extraction. Br. J. Ophthalmol. 75:547-551, 1991.
31. Flesner, P., Sander, B., Henning, V., Parving, H.-H., Dornonville de la Cour, M., and Lund-Anderson, H. Cataract surgery on diabetic patients. A prospective evaluation of risk factors and complications. Acta. Ophthalmol. Scand. 80:19-24, 2002.
32. Kato, S., Fukada, Y., Hori, S., Tanaka, Y., and Oshika, T. Influence of phacoemulsification and intraocular lens implantation on the course of diabetic retinopathy. J. Cataract. Refract. Surg. 25:788-793, 1999. (Pubitemid 29272772)
33. Tsujikawa, A., Otani, A., Takanashi, T., and Ogura, Y. Longterm prognosis of extracapsular cataract extraction and intraocular lens implantation in diabetic patients. Jap. J. Opthalmol. 41:319-323, 1997. (Pubitemid 27474584)
34. Squirrell, D., Bhola, R., Bush, J., Winder, S., and Talbot, J.F. A prospective, case controlled study of the natural history of diabetic retinopathy and maculopathy after uncomplicated phacoemulsification cataract surgery in patients with type 2 diabetes. Br. J. Ophthalmol. 86:565-571, 2002. (Pubitemid 34454505)
35. Krepler, K., Biowski, R., Schrey, S., Jandrasits, K., and Wedrich, A. Cataract surgery in patients with diabetic retinopathy: visual outcome, progression of diabetic retinopathy, and incidence of diabetic macular edema. Graefes. Arch. Clin. Exp. Ophthalmol. 240:735-738, 2002. (Pubitemid 36097101)
36. Sebestyen, J.G. Intraocular lenses and diabetes mellitus. Am. J. Ophthalmol. 101:425-428, 1986. (Pubitemid 16111090)
37. Mittra, R.A., Borrillo, J.L., Dev, S., Mieler, W.F., and Koenig, S.B. Retinopathy progression and visual outcomes after phacoemulsification in patients with diabetes mellitus. Arch. Ophthalmol. 118:912-917, 2000. (Pubitemid 30460628)
38. Wagner, T., Knaflic, D., Rauber, M., and Mester, U. Influence of cataract surgery on the diabetic eye: a prospective study. Ger. J. Ophthalmol. 5:79-83, 1996.
39. Lanzagorta-Aresti, A., Palacios-Pozo, E., Menezo Rozalen, J.L., and Navea-Tejerina, A. Prevention of vision loss after cataract surgery in diabetic macular edema with intravitreal bevacizumab: a pilot study. Retina 29:530-535, 2009.
40. Takamura, Y., Kubo, E., and Akagi, Y.Y. Analysis of the effect of intravitreal bevacizumab injection on diabetic macular edema after cataract surgery. Ophthalmology 116: 1151-1157, 2009.
41. Akinci, A., Batman, C., Ozkilic, E., and Altinsoy, A. Phacoemulsification with intravitreal bevacizumab injection in diabetic patients with macular edema and cataract. Retina 29:1432-1143, 2009.
42. Cheema, R.A., Al-Mubarak, M.M., Amin, Y.M., and Cheema, M.A. Role of combined cataract surgery and intravitreal bevacizumab injection in preventing progression of diabetic retinopathy: prospective randomized study. J. Cataract Refract. Surg. 35:18-25, 2009.
43. Benson, W.E., Brown, G.C., Tasman, W., McNamara, J.A., and Vander, J.F. Extracapsular cataract extraction with placement of a posterior chamber lens in patient with diabetic retinopathy. Ophthalmology 100:730-738, 1993. (Pubitemid 23143896)
44. Pollack, A., Lebia, H., Bukelman, A., and Oliver, M. The course of diabetic retinopathy following cararact surgery in eyes previously treated by laser photocoagulation. Br. J. Ophthalmol. 76:228-231, 1992.
45. Kodama, T., Hayasaka, S., and Setogawa, T. Plasma glucose levels, postoperative complications, and progression of retinopathy in diabetic patients undergoing intraocular lens implantation. Graefes. Arch. Clin. Exp. Ophthalmol. 231:439-443, 1993. (Pubitemid 23264116)
46. Ruiz, R., and Saatci, O.A. Posterior chamber lens implantation in eyes with inactive and active proliferative diabetic retinopathy. Am. J. Ophthalmol. 111:158-162, 1991.
47. Antcliff, R.J., Poulson, A., and Flanagan, D.W. Phacoemulsification in diabetics. Eye 10:737-741, 1996. (Pubitemid 27037568)
48. Chatterjee, S., Savant, V.V., and Stavrou, P. Diabetic retinopathy progression and visual outcome after phacoemulsification in South-Asian and Afro-Caribbean patients with diabetes. Eye 18:575-579, 2004. (Pubitemid 38961449)
49. Arevalo, J.F., Fromow-Guerra, J., Quiroz-Mercado, H., et al. Pan-American Collaborative Retina Study Group. Primary intravitreal bevacizumab (Avastin) for diabetic macular edema: results from the Pan-American Collaborative Retina Study Group at 6-month follow-up. Ophthalmology 114:743-750, 2007. (Pubitemid 46483714)
50. Udaondo, P., Garcia-Pous, M., Garcia-Delpech, S., Salom, D., and Diaz-Llopis, M. Prophylaxis of macular edema with intravitreal ranibizumab in patients with diabetic retinopathy after cataract surgery: a pilot study. J. Ophthalmol. 2011: 159436, 2011.
51. Mechini, U., Cappelli, S., and Virgili, G. Cataract surgery and diabetic retinopathy. Semin. Ophthalmol. 18:103-108, 2003. (Pubitemid 38404833)
52. Ivancic, D., Mandic, Z., Barac, C., and Kopic, M. Cataract surgery and post operative complication in diabetic patients. Coll. Antropol. 29:55-58, 2005. (Pubitemid 41265100)
53. Dowler, J.G., Hykin, P.G., Lightman, S.L., and Hamilton, A.M. Visual acuity following extracapsular cataract extraction in diabetics: a meta-analysis. Eye 9: 313-317, 1995.
54. Kim, S.J., Equi, R., and Bressler, N.M. Analysis of macular edema after cataract surgery in patients with diabetes using optical coherence tomography. Ophthalmology 114:881-889, 2007. (Pubitemid 46635831)
55. Fard, M.A., Yazdanei Abyane, A., and Malihi, M. Prophylactic intravitreal bevacizumab for diabetic macular edema (thickening) after cataract surgery: prospective randomized study. Eur. J. Ophthalmol. 21:276-281, 2011.
56. Flanagan, D.W. Progression of diabetic retinopathy following cataract surgery: can it be prevented? (Editorial) Br. J. Ophthalmol. 80:778-779, 1996.
57. Estabrook, E.J., Madhusudhana, K.C., Hannan, S.R., and Newsom, R.S. Can optical coherence tomography predict the outcome of laser photocoagulation for diabetic macular edema? Ophthalmic Surg Lasers Imaging 38:478-483, 2007.
58. Krzystolik, M.G., Filippopoulos, T., Ducharme, J.F., and Loewenstein, J.I. Pegaptanib as an adjunctive treatment for complicated neovascular diabetic retinopathy. Arch. Ophthalmol. 124:920-921, 2006. (Pubitemid 43877695)
59. Macugen Diabetic Retinopathy Study Group. Changes in retinal neovascularization after pegaptanib (Macugen) therapy in diabetic individuals. Ophthalmology 113:23-28, 2006.
60. Lam, D.S.C., Chan, C.K.M., Mohamed, S., Lai, T.Y.Y., Lee, V.Y.W., Lai, W.W., et al. Phacoemulsification with intravitreal triamcinolone in patients with cataract and coexisting diabetic,macular oedema: a 6-month prospective pilot study. Eye 19:885-890, 2005. (Pubitemid 41195142)
61. Habib, M.S., Cannon, P.S., and Steel, D.H. The combination of intravitreal triamcinolone and phacoemulsification surgery in patients with diabetic foveal oedema and cataract. BMC Ophthalmol. 22:15, 2005.
62. Mirshahi, A., Roohipoor, R., Lashay, A., Mohammadi, S.-F., Abdoallahi, A., and Faghihi, H. Bevacizumab-augmented retinal laser photocoagulation in proliferative diabetic retinopathy: a randomized double-masked clinical trial. Eur. J. Ophthalmol. 18:263-269, 2008. (Pubitemid 351692187)
63. Minnella, A.M., Savastano, C.M., Ziccardi, L., Scupola, A., Falsini, B., and Balestrazzi, E. Intravitreal bevacizumab (Avastin) in proliferative diabetic retinopathy. Acta. Ophthalmol. (Copenh). 86:683-687, 2008.
64. Paccola, L., Costa, R.A., Folgosa, M.S., Barbosa, J.C., Scott, I.U., and Jorge, R. Intravitreal triamcinolone versus bevacizumab for treatment of refractory diabetic macular oedema (IBEME study). Br. J. Ophthalmol. 92:76-80, 2008.
65. Kumar, A., and Sinha, S. Intravitreal bevacizumab (Avastin) treatment of diffuse diabetic macular edema in an Indian population. Indian J Ophthalmol. 55:451-455, 2007.
66. Arevalo, J.F., Wu, L., Sanchez, J.G., Maia, M., Saravia, M.J., Fernandez, C.F., and Evans, T. Intravitreal bevacizumab (Avastin) for proliferative diabetic retinopathy: 6-months follow-up. Eye 23:117-123, 2009.
67. Haritoglou, C., Kook, D., Neubauer, A., Wolf, A., Priglinger, S., Strauss, R., et al. Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema. Retina 26:999-1005, 2006. (Pubitemid 44973218)